111 Inc (YI)

111, Inc. is an American depositary receipt listed on NASDAQ that represents common stock of the underlying issuer. The company, together with its subsidiaries, operates an integrated online and offline healthcare platform in the People's Republic of China. Its business is organized into B2C and B2B segments and includes supply chain integration services, product promotion, customer analytics, patient education, brand awareness support, and marketing and channel data services. Through its online pharmacies, it provides pharmaceutical and health and wellness products, including prescription and over-the-counter medicines, nutritional supplements, contact lenses, medical supplies and devices, and personal care items. The company also offers cloud-based inventory management, smart procurement, online loan application, consultation, e-prescription, and data services, along with warehousing, logistics, research and development, consulting, and IT support. Founded in 2010 and headquartered in Shanghai, it was formerly known as New Peak Group before adopting the 111, Inc. name in 2018.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.